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Introduction
Juvenile dermatomyositis is a chronic inflammatory mus-
cular disease that affects every year 1.5-3 children permil-
lion and also produces systemic, skin, joint, digestive and
respiratory manifestations.
Objectives
To describe the main epidemiological, clinical andanaly-
tical aspects of Juvenile dermatomyositis diagnosed in
La Fe Hospital (Valencia, Spain).
Methods
Patients diagnosed of Juvenile dermatomyositis in La Fe
Hospital (Valencia, Spain) since June 1992 to March 2013.
Dates are shown in median and interquartile range for
non-parametric variables, and for parametric variables is
given as mean and standard deviation. To assess response
to treatment, we used Wilcoxon test for paired measures
of non-parametric variables and t-student for parametric
variables.
Results
We included 22 patients, 45.5% women, age at diagnosis
7.6 (3.7-10.8) years and evolution time 2.75 (1-5)
months.
The most frequent initial manifestation were muscle
weakness (40%) and skin alterations (40%). Also constitu-
tional symptoms (15%) and myalgia (5%). They presented
muscle weakness (100%), heliotrope rash (100%), Gottron
papules (90.9%), calcinosis (27.3%), other skin lesions such
as telangiectasias, oral ulcers, livedo reticularis and pur-
pura (55.5%), mialgia (55.5%), arthralgia (55.5%), arthritis
(50%), constitutional symptoms (50%), esophageal involve-
ment (31.8%), gastrointestinal (28.6%), Raynaud (18.2%),
fever (27.3%), anasarca (18.2%), dysphonia (18.2%), and
lung disease (18.2%).
Patients were treated with corticosteroids, immunoglo-
bulins and immunosuppressants such as methotrexate,
tacrolimus, cyclosporine and antimalarial, alone or in
combination, with significant improvement.
CPK at diagnosis was 1114 UI/I (280-4952), and 73 (46-
106) after 3 months, with significant improvement (p =
0.0010). Aldolase at diagnosis 15.45 U/L (12-37) and 6 (4-
10)after 3 months (p = 0.0148). GOT at diagnosis 149 U/L
(73-180) and 28 (25-38) after a year (p = 0.0005). GPT at
diagnosis 102 U/L (44-187) and 23 (17-36) after a year (p
= 0.0003). ESR at diagnosis 18 mm (16-36.5) and 13 (7-18)
after a year (p = 0.0139). Strength at diagnosis was 2.5 ± 1
and 4.25 ± 0.87 after 3 months (p < 0.00001).
Capilarocopy was realised in most of patients at diagno-
sis and showed pathological capillary patterns (decrease in
the number of capillaries, enlargement, megacapillaries,
and bleeding), with improvement in subsequent
assessments.
Conclusion
Dermatomyositis is a rare disease of childhood. Children
we presented had muscle weakness and heliotrope
erythema (100%) and in varying proportions Gottron’s
papules, calcinosis, Raynaud, artromialgias and general
symptoms. We propose a comprehensive patient moni-
toring, assessing muscle strength and laboratory findings
as CPK, aldolase, GOT, GPT and ESR but also by capil-
laroscopy. Capillaroscopy may be indicative of dermato-
myositis outbreak, has diagnosis value and may observe
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